Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6621 Fannin St
Wb1100
Houston, TX 77030Phone+1 832-824-6422Fax+1 832-825-0164
Summary
- Dr. Hao Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Connecticut, and New York.
Education & Training
Boston Children’s HospitalFellowship, Pediatric Pathology, 2013 - 2014
Boston University Medical CenterFellowship, Cytopathology, 2012 - 2013
Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 2008 - 2009
Xian Medicine UniversityClass of 2008
Certifications & Licensure
CT State Medical License 2021 - 2025
NY State Medical License 2019 - 2023
TX State Medical License 2014 - 2019
MA State Medical License 2012 - 2017- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Pathology - Pediatric
Publications & Presentations
PubMed
- 65 citationsTargeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.Setu M Vora, Pietro Fontana, Tianyang Mao, Valerie Leger, Ying Zhang
Proceedings of the National Academy of Sciences of the United States of America. 2022-03-01 - andAssociated Extensive Prolapse-Type Inflammatory Polyposis in Crohn's Colitis.Ting Zhou, Kalyani Patel, R Alan Harris, Victor Seghers, Seema M Walsh
Annals of Clinical and Laboratory Science. 2021-11-01 - 34 citationsMultiple domain interfaces mediate SARM1 autoinhibition.Chen Shen, Mihir Vohra, Pengfei Zhang, Xianrong Mao, Matthew D. Figley
Proceedings of the National Academy of Sciences of the United States of America. 2021-01-26
Press Mentions
- The Prevalence of Cryptococcal Antigen (CrAg) and Benefits of Pre-Emptive Antifungal Treatment Among HIV-Infected Persons with CD4+ T-cell Counts < 200 Cells/μL: Evidence Based on a Meta-AnalysisJune 12th, 2020
